Archive - 2018

31 December 2018 - Press Releases

2018 Operational Update

Oxfordshire, UK, 31 December 2018 – Karus Therapeutics Ltd (‘Karus’), a leader in the design and development of innovative medicines with breakthrough potential in the treatment of cancer, provides an update on its clinical, preclinical, financing and operational progress in 2018.

Read more

Events

13 December 2018
Genesis 2018, London, UK

Events

13-16 November 2018
30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Dublin, Ireland

Events

5-7 November 2018
BIO-Europe, Copenhagen, Denmark & Malmö, Sweden

Events

4-6 November 2018
NCRI Cancer Conference, Glasgow, UK

Events

18 October 2018
BIA UK Bioscience Forum, London, UK

Events

9-10 October 2018
ELRIG Drug Discovery 2018, London, UK

Publications

Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy
David Gyori, Ee Lyn Lim, Francis M. Grant, Dominik Spensberger, Rahul Roychoudhuri, Stephen J. Shuttleworth, Klaus Okkenhaug, Len R. Stephens, Phillip T. Hawkins
JCI Insight 2018, 3(11), e120631